EMA publishes follow-up guidelines for ATMPs

EMA released revised guidelines on safety and efficacy follow-up and risk management of advanced therapy medicinal products (ATMPs), which include therapies made from genes, tissue or cells. The guidelines include procedures to enable

Read the full 335 word article

User Sign In